Former Pharma CEO Pleads Guilty to Bribing Doctors to Prescribe Opioids
Former CEO of pharmaceutical company, Insys, pleaded guilty to bribing doctors to prescribe opioids. Michael Babich could serve 25 years in prison.
Prescription Drugs
Lucemyra, A New Non-Opioid for Opioid Withdrawal
Back in May of 2018, the FDA approved Lucemyra, a new medication to treat the symptoms of opioid withdrawal. It is available as of August of 2018.
5 Reasons Why Lean Is Still a Dangerous Drug
Lean is still a dangerous drug, though it has been glorified in pop lyrics. Codeine addiction can be just as life-threatening as many opioids if untreated.
Dsuvia: The New FDA-Approved Opioid 1,000 Times Stronger than Morphine
Despite the ongoing opioid epidemic, the FDA has approved Dsuvia, a synthetic opioid that is 10 times more potent than fentanyl.
Opioid Package Passed by Senate, 98-1 Bipartisan Vote
On October 3rd, 2018, the Senate passed an opioid package that contained several bills that have all faced contention in the past.
News: 27 States Have Filed Lawsuits Against Opioid Manufacturer
More and more frequently, states have filed lawsuits against opioid manufacturers. It essentially comes down to two factors: advertising and distribution.
The 5 Most Commonly Abused Drugs On College Campuses
The rates of abuse of drugs on college campuses have more than tripled for some substances, leading to increased tolerance and possible addiction later on. Although many drugs are frequently used by college students, here are the 5 most commonly abused drugs on college campuses.
The Relationship Between Drugs and Gun Violence
The relationship between drugs and gun violence is a very complex one. Because both are serious problems facing American society it is critical that we seek to understand their interaction and try to identify possible solutions. Lives depend on it.
Can A Small Louisiana Town End An Opioid Manufacturer’s Sketchy Marketing?
A small town in Louisiana is attempting to fight the opioid epidemic that is ravaging the state through the use of lawsuits against opioid manufacturers. It is hoped that the lawsuit will act as an impetus for opioid manufacturers to change their ways and provide necessary funding for prevention and treatment efforts.
